Characterization of the CYP3A4 active site by homology modeling.

Chem Pharm Bull (Tokyo)

Pharmaceutical Research Division, Takeda Chemical Industries, Ltd. Osaka, Japan.

Published: July 2004

Human microsomal cytochrome P450s participate in drug metabolism and detoxification. Among them, CYP3A4 is the most important isoform for drug-drug interactions. To gain a better understanding of the active site, a homology model of CYP3A4 was constructed based on the crystallographic coordinates of mammalian CYP2C5. The putative active site is much larger than that of CYP2C5 and is divided into three parts (i.e. a proximal and two distal sites from the heme). Most residues reported to be important for ligand-binding are located in the active site of the model. Moreover, some inhibitors (paclitaxel etc.) docked into the model have complementary shapes to the pocket. Pharmacophore docking of 14 substrates was also performed using Ph4Dock of MOE. Calculated interaction energies showed a moderate correlation with the logarithm of apparent K(m) values. These results suggest that this model is reliable enough to be used in the design of compounds for removing undesirable CYP3A4 inhibition.

Download full-text PDF

Source
http://dx.doi.org/10.1248/cpb.52.830DOI Listing

Publication Analysis

Top Keywords

active site
16
site homology
8
characterization cyp3a4
4
active
4
cyp3a4 active
4
site
4
homology modeling
4
modeling human
4
human microsomal
4
microsomal cytochrome
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!